These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 17127389)
21. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762 [TBL] [Abstract][Full Text] [Related]
22. The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b). Wagner KD; Wagner N; Schley G; Theres H; Scholz H Gene; 2003 Feb; 305(2):217-23. PubMed ID: 12609742 [TBL] [Abstract][Full Text] [Related]
23. Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells. Qi H; Labrie Y; Grenier J; Fournier A; Fillion C; Labrie C Mol Cell Endocrinol; 2001 Sep; 182(2):181-92. PubMed ID: 11514053 [TBL] [Abstract][Full Text] [Related]
24. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one. Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038 [TBL] [Abstract][Full Text] [Related]
25. Pitfall of an internal control plasmid: response of Renilla luciferase (pRL-TK) plasmid to dihydrotestosterone and dexamethasone. Ibrahim NM; Marinovic AC; Price SR; Young LG; Fröhlich O Biotechniques; 2000 Oct; 29(4):782-4. PubMed ID: 11056808 [TBL] [Abstract][Full Text] [Related]
26. Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex. Lu S; Jenster G; Epner DE Mol Endocrinol; 2000 May; 14(5):753-60. PubMed ID: 10809237 [TBL] [Abstract][Full Text] [Related]
27. Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxins. Liu X; Kramer JA; Swaffield JC; Hu Y; Chai G; Wilson AG Mutat Res; 2008 May; 653(1-2):63-9. PubMed ID: 18485802 [TBL] [Abstract][Full Text] [Related]
28. Activation of the control reporter plasmids pRL-TK and pRL-SV40 by multiple GATA transcription factors can lead to aberrant normalization of transfection efficiency. Ho CK; Strauss JF BMC Biotechnol; 2004 Apr; 4():10. PubMed ID: 15119957 [TBL] [Abstract][Full Text] [Related]
29. The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein. Montano G; Ullmark T; Jernmark-Nilsson H; Sodaro G; Drott K; Costanzo P; Vidovic K; Gullberg U Leuk Res; 2016 Jan; 40():60-7. PubMed ID: 26563595 [TBL] [Abstract][Full Text] [Related]
30. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain. Deuel TF; Guan LS; Wang ZY Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756 [TBL] [Abstract][Full Text] [Related]
31. A protocol for combined Photinus and Renilla luciferase quantification compatible with protein assays. Hampf M; Gossen M Anal Biochem; 2006 Sep; 356(1):94-9. PubMed ID: 16750160 [TBL] [Abstract][Full Text] [Related]
32. Coexpression of Wilms' tumor suppressor 1 (WT1) and androgen receptor (AR) in the genital tract of human male embryos and regulation of AR promoter activity by WT1. Köhler B; Delezoide AL; Boizet-Bonhoure B; McPhaul MJ; Sultan C; Lumbroso S J Mol Endocrinol; 2007 May; 38(5):547-54. PubMed ID: 17496156 [TBL] [Abstract][Full Text] [Related]
33. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells. Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727 [TBL] [Abstract][Full Text] [Related]
34. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1. Matsuzawa-Watanabe Y; Inoue J; Semba K Oncogene; 2003 Sep; 22(39):7900-4. PubMed ID: 12970737 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881). van Roijen JH; Ooms MP; Weber RF; Brinkmann AO; Grootegoed JA; Vreeburg JT J Androl; 1997; 18(1):51-61. PubMed ID: 9089068 [TBL] [Abstract][Full Text] [Related]
36. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. Ripple MO; Henry WF; Rago RP; Wilding G J Natl Cancer Inst; 1997 Jan; 89(1):40-8. PubMed ID: 8978405 [TBL] [Abstract][Full Text] [Related]
37. Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line. Cinar B; Koeneman KS; Edlund M; Prins GS; Zhau HE; Chung LW Cancer Res; 2001 Oct; 61(19):7310-7. PubMed ID: 11585771 [TBL] [Abstract][Full Text] [Related]
38. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912 [TBL] [Abstract][Full Text] [Related]
39. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNcaP prostatic adenocarcinoma cells. Goossens K; Esquenet M; Swinnen JV; Manin M; Rombauts W; Verhoeven G Mol Cell Endocrinol; 1999 Sep; 155(1-2):9-18. PubMed ID: 10580834 [TBL] [Abstract][Full Text] [Related]
40. Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes. Montano G; Cesaro E; Fattore L; Vidovic K; Palladino C; Crescitelli R; Izzo P; Turco MC; Costanzo P Hum Mol Genet; 2013 May; 22(9):1771-82. PubMed ID: 23362234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]